Scholarlink

Background <p>Primary pulmonary mucoepidermoid carcinoma (PMEC) is a rare malignancy with no standardized prognostic tools. This study aimed to investigate whether specific surgical approaches significantly impact survival outcomes and to develop an accurate predictive nomogram incorporating surgical variables.</p> Methods <p>Using the SEER database (2004–2020), we identified 225 PMEC patients. Independent prognostic factors were selected via Cox regression (<i>P</i> &lt; 0.05). A nomogram was developed and validated using time-dependent ROC curves, calibration plots, and decision curve analysis (DCA).</p> Results <p>We analyzed 225 PMEC cases, predominantly affecting patients aged 30–69 years with slight male predominance. Most tumors (30–52&#xa0;mm) were early-stage with favorable prognosis; only 11.01% presented as Stage IV (3-year OS: 18.5%, median survival: 8.5 months). The nomogram (incorporating age, tumor size, N/M stage, surgery, and chemotherapy) demonstrated excellent discrimination (AUC &gt; 0.9) and calibration, with pneumonectomy plus lymph node dissection showing the best surgical outcomes.</p> Conclusion <p>Our nomogram provides a clinically useful tool for PMEC prognostication, validating that lymph node dissection during lobectomy significantly improves survival. It may guide individualized surgical decisions for this rare malignancy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A surgical strategy-based nomogram for primary pulmonary mucoepidermoid carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月15日

查看全文
  • Lei Yu,
  • Yanling Peng,
  • Shan Lan,
  • Lu Yang

摘要

Background

Primary pulmonary mucoepidermoid carcinoma (PMEC) is a rare malignancy with no standardized prognostic tools. This study aimed to investigate whether specific surgical approaches significantly impact survival outcomes and to develop an accurate predictive nomogram incorporating surgical variables.

Methods

Using the SEER database (2004–2020), we identified 225 PMEC patients. Independent prognostic factors were selected via Cox regression (P < 0.05). A nomogram was developed and validated using time-dependent ROC curves, calibration plots, and decision curve analysis (DCA).

Results

We analyzed 225 PMEC cases, predominantly affecting patients aged 30–69 years with slight male predominance. Most tumors (30–52 mm) were early-stage with favorable prognosis; only 11.01% presented as Stage IV (3-year OS: 18.5%, median survival: 8.5 months). The nomogram (incorporating age, tumor size, N/M stage, surgery, and chemotherapy) demonstrated excellent discrimination (AUC > 0.9) and calibration, with pneumonectomy plus lymph node dissection showing the best surgical outcomes.

Conclusion

Our nomogram provides a clinically useful tool for PMEC prognostication, validating that lymph node dissection during lobectomy significantly improves survival. It may guide individualized surgical decisions for this rare malignancy.